Guy U.
- Country
- Germany
- Department
- Service d'Oncologie Multidisciplinaire et Innovation thérapeutique
Research Overview
- A Phase I/II Study of KISIMA-02 Vaccine-Based Immunotherapy in KRAS G12D/G12V Mutated Pancreatic Ductal Adenocarcinoma Patients
- Phase I Study of BI 3923948 Monotherapy and in Combination with an Anti-PD-1 Antibody in Patients with Advanced, Unresectable, or Metastatic Solid Tumors
- Evaluation of Safety and Preliminary Efficacy of CLDN6 CAR-T and CLDN6 RNA-LPX in CLDN6-Positive Relapsed or Refractory Advanced Solid Tumors
Data & Insights
Has run more than one trial at 5 of 44 partner sites.
Specializations
Oncology and Immunotherapy
This investigator specializes in developing innovative treatments for solid tumors, with particular emphasis on immunotherapy approaches and cell-based therapies. Their research encompasses novel therapeutic strategies including CAR-T cell therapy and RNA-based vaccines.
- Advanced Cancer Treatment
- Cellular Immunotherapy
- Therapeutic Vaccines
Specialized Cancer Types
The investigator focuses on multiple cancer indications including melanoma, non-small cell lung cancer, colorectal cancer, and triple negative breast cancer. They have particular expertise in treating pancreatic ductal adenocarcinoma with mutation-specific approaches.
- Solid Tumor Oncology
- Sarcoma Treatment
- Targeted Cancer Therapy
Innovative Treatment Approaches
Their therapeutic arsenal includes oncolytic virus therapy combined with tumor-specific peptides and various immunotherapy combinations. The investigator works with antibody-based treatments and explores novel combinations of immunotherapeutic agents.
- Combination Immunotherapy
- Personalized Cancer Treatment
- Advanced Therapeutic Protocols
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.